• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在药物评估期间识别有QT间期延长风险的患者:一个被错过的机会?

Identification of Patients At-Risk of QT Interval Prolongation during Medication Reviews: A Missed Opportunity?

作者信息

Buss Vera H, Lee Kayla, Naunton Mark, Peterson Gregory M, Kosari Sam

机构信息

Faculty of Health, University of Canberra, Bruce, ACT 2617, Australia.

School of Medicine, University of Tasmania, Sandy Bay, TAS 7005, Australia.

出版信息

J Clin Med. 2018 Dec 10;7(12):533. doi: 10.3390/jcm7120533.

DOI:10.3390/jcm7120533
PMID:30544669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6306817/
Abstract

The prolongation of the QT interval is a relatively rare but serious adverse drug reaction. It can lead to torsade de pointes, which is potentially life-threatening. The study's objectives were: determine the use of QT interval-prolonging drugs in an elderly community-dwelling population at risk of medication misadventure and identify recommendations regarding the risk of QT interval prolongation made by pharmacists when performing medication reviews. In a retrospective evaluation, 500 medication review reports from Australian pharmacists were analysed. In patients taking at least one QT interval-prolonging drug, the individual risk of drug-induced QT interval prolongation was assessed. Recommendations of pharmacists to avoid the occurrence of this drug-related problem were examined. There was a high prevalence of use of potentially QT interval-prolonging drugs (71% patients), with 11% of patients taking at least one drug with a known risk. Pharmacists provided specific recommendations in only eight out of 35 patients (23%) with a high-risk score and taking drugs with known risk of QT interval prolongation. Pharmacists' recommendations, when present, were focused on drugs with known risk of QT interval prolongation, rather than patients' additional risk factors. There is a need to improve knowledge and awareness of this topic among pharmacists performing medication reviews.

摘要

QT间期延长是一种相对罕见但严重的药物不良反应。它可导致尖端扭转型室性心动过速,这可能危及生命。该研究的目的是:确定在有用药差错风险的老年社区居住人群中QT间期延长药物的使用情况,并确定药剂师在进行药物审查时就QT间期延长风险提出的建议。在一项回顾性评估中,分析了来自澳大利亚药剂师的500份药物审查报告。在服用至少一种QT间期延长药物的患者中,评估了药物引起的QT间期延长的个体风险。审查了药剂师为避免出现这种药物相关问题而提出的建议。潜在的QT间期延长药物的使用率很高(71%的患者),11%的患者服用至少一种有已知风险的药物。在35名高危评分且服用有已知QT间期延长风险药物的患者中,只有8名(23%)患者得到了药剂师的具体建议。药剂师的建议(如有)主要集中在有已知QT间期延长风险的药物上,而不是患者的其他风险因素。有必要提高进行药物审查的药剂师对该主题的知识和认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/774d/6306817/a5e3e807cfe0/jcm-07-00533-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/774d/6306817/a5e3e807cfe0/jcm-07-00533-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/774d/6306817/a5e3e807cfe0/jcm-07-00533-g001.jpg

相似文献

1
Identification of Patients At-Risk of QT Interval Prolongation during Medication Reviews: A Missed Opportunity?在药物评估期间识别有QT间期延长风险的患者:一个被错过的机会?
J Clin Med. 2018 Dec 10;7(12):533. doi: 10.3390/jcm7120533.
2
Identification of Risk of QT Prolongation by Pharmacists When Conducting Medication Reviews in Residential Aged Care Settings: A Missed Opportunity?药剂师在老年护理机构进行药物审查时识别QT间期延长风险:一个被错过的机会?
J Clin Med. 2019 Nov 4;8(11):1866. doi: 10.3390/jcm8111866.
3
[Drug-drug interactions with risk of QT-prolongation. A epidemiological study in Belgian community pharmacies].[具有QT间期延长风险的药物相互作用。比利时社区药房的一项流行病学研究]
J Pharm Belg. 2016 Dec(4):14-23.
4
Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.常见基因变异风险评分与药物诱导的QT间期延长及尖端扭转型室速风险相关:一项初步研究。
Circulation. 2017 Apr 4;135(14):1300-1310. doi: 10.1161/CIRCULATIONAHA.116.023980. Epub 2017 Feb 17.
5
Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.老年患者药物性尖端扭转型室速中QT间期延长剂的鲁莽使用。
Z Gerontol Geriatr. 2018 Jan;51(1):41-47. doi: 10.1007/s00391-016-1155-5. Epub 2016 Nov 22.
6
Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives.抗癌药物相关的QTc间期延长、尖端扭转型室速和猝死:当前证据与未来研究展望
Oncotarget. 2018 May 22;9(39):25738-25749. doi: 10.18632/oncotarget.25008.
7
Acquired prolongation of QT interval as a risk factor for torsade de pointes ventricular tachycardia: a narrative review for the anesthesiologist and intensivist.获得性QT间期延长作为尖端扭转型室性心动过速的危险因素:给麻醉医生和重症监护医生的叙述性综述
J Anesth. 2017 Jun;31(3):413-423. doi: 10.1007/s00540-017-2314-6. Epub 2017 Feb 22.
8
Frequency, characteristics and nature of risk factors associated with use of QT interval prolonging medications and related drug-drug interactions in a cohort of psychiatry patients.在一组精神科患者中,与 QT 间期延长药物的使用及相关药物相互作用相关的风险因素的频率、特征和性质。
Therapie. 2019 Dec;74(6):599-609. doi: 10.1016/j.therap.2019.03.008. Epub 2019 Apr 4.
9
Prevalence and determinants of QT interval prolongation in medical inpatients.内科住院患者 QT 间期延长的发生率及影响因素。
Intern Med J. 2012 Aug;42(8):933-40. doi: 10.1111/j.1445-5994.2011.02447.x.
10
QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.QT 间期延长与尖端扭转型室性心动过速风险:临床医生必备知识。
Curr Med Res Opin. 2013 Dec;29(12):1719-26. doi: 10.1185/03007995.2013.840568. Epub 2013 Sep 23.

引用本文的文献

1
Salidroside ameliorates abnormalities in electrophysiological indices induced by perfusion of the heart with low-potassium solutions.红景天苷可改善低钾溶液灌注心脏所诱导的电生理指标异常。
Front Cardiovasc Med. 2025 Aug 12;12:1628940. doi: 10.3389/fcvm.2025.1628940. eCollection 2025.
2
Risk Stratification of QTc Prolongations in Hospitalized Cardiology and Gastroenterology Patients Using the Tisdale Score-A Retrospective Analysis.使用蒂斯代尔评分对住院心脏病学和胃肠病学患者QTc延长进行风险分层——一项回顾性分析
J Clin Med. 2025 Jan 8;14(2):339. doi: 10.3390/jcm14020339.
3
Use of Drugs Associated with QT Interval Prolongation at the Hospital Level during the COVID-19 Pandemic in Colombia.

本文引用的文献

1
Impact of Pharmacist Intervention on Electrocardiogram Monitoring of Pediatric Patients on Multiple QTc Interval-Prolonging Medications.药师干预对使用多种可延长QTc间期药物的儿科患者心电图监测的影响。
J Pediatr Pharmacol Ther. 2017 Nov-Dec;22(6):399-405. doi: 10.5863/1551-6776-22.6.399.
2
QTc prolongation in acute medical admissions: an often overlooked and potentially serious finding.急性内科住院患者中的QTc延长:一个常被忽视且可能严重的发现。
Postgrad Med J. 2018 Feb;94(1108):123-124. doi: 10.1136/postgradmedj-2017-135208. Epub 2017 Sep 28.
3
Development of a risk score for QTc-prolongation: the RISQ-PATH study.
哥伦比亚新冠疫情期间医院层面与QT间期延长相关药物的使用情况
Int J Vasc Med. 2022 Sep 21;2022:3045942. doi: 10.1155/2022/3045942. eCollection 2022.
4
Risk assessment tools for QT prolonging pharmacotherapy in older adults: a systematic review.老年人 QT 延长药物治疗风险评估工具:系统评价。
Eur J Clin Pharmacol. 2022 May;78(5):765-779. doi: 10.1007/s00228-022-03285-3. Epub 2022 Feb 14.
5
Implementation of a Pharmacist Monitoring Process for Patients on QTc Prolonging Antibiotics: A Pilot Study.对使用可延长QTc的抗生素患者实施药师监测流程:一项试点研究。
Hosp Pharm. 2021 Dec;56(6):772-776. doi: 10.1177/0018578720965429. Epub 2020 Oct 20.
6
Protocol-based cardiotoxicity monitoring in hydroxychloroquine medicated COVID-19 pediatric patients.基于方案的羟氯喹治疗的COVID-19儿科患者心脏毒性监测
Rev Port Cardiol. 2022 Feb;41(2):155-163. doi: 10.1016/j.repc.2021.01.018. Epub 2021 Sep 22.
7
Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease.血液透析患者和非终末期肾病患者使用 QT 延长药物。
J Am Heart Assoc. 2020 Jul 7;9(13):e015969. doi: 10.1161/JAHA.120.015969. Epub 2020 Jun 24.
8
Identification of Risk of QT Prolongation by Pharmacists When Conducting Medication Reviews in Residential Aged Care Settings: A Missed Opportunity?药剂师在老年护理机构进行药物审查时识别QT间期延长风险:一个被错过的机会?
J Clin Med. 2019 Nov 4;8(11):1866. doi: 10.3390/jcm8111866.
9
Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study.土耳其一所教学医院老年病房的药师干预和常用药物评估:一项回顾性研究。
Clin Interv Aging. 2019 Mar 21;14:587-600. doi: 10.2147/CIA.S201039. eCollection 2019.
QTc延长风险评分的开发:RISQ-PATH研究
Int J Clin Pharm. 2017 Apr;39(2):424-432. doi: 10.1007/s11096-017-0446-2. Epub 2017 Mar 9.
4
Risk factors for QTc-prolongation: systematic review of the evidence.致 QT 间期延长的风险因素:证据的系统综述。
Int J Clin Pharm. 2017 Feb;39(1):16-25. doi: 10.1007/s11096-016-0414-2. Epub 2016 Dec 23.
5
Clinical pharmacists' opportunities to reduce inappropriate prescription of QT-prolonging medications: calls to action.临床药师减少QT延长药物不适当处方的机会:行动呼吁。
Int J Pharm Pract. 2017 Apr;25(2):176-179. doi: 10.1111/ijpp.12303. Epub 2016 Sep 28.
6
Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management.药物诱导的QT间期延长和尖端扭转型室速:药师在风险评估、预防及管理中的作用
Can Pharm J (Ott). 2016 May;149(3):139-52. doi: 10.1177/1715163516641136. Epub 2016 Apr 8.
7
Understanding, benefits and difficulties of home medicines review - patients' perspectives.居家药物评估的理解、益处及困难——患者视角
Aust Fam Physician. 2015 Apr;44(4):249-53.
8
QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.QT 间期延长与尖端扭转型室性心动过速风险:临床医生必备知识。
Curr Med Res Opin. 2013 Dec;29(12):1719-26. doi: 10.1185/03007995.2013.840568. Epub 2013 Sep 23.
9
Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice.药物引起的 QT 间期延长:临床实践中 QT 间期的测量和评估。
Br J Clin Pharmacol. 2013 Jul;76(1):48-57. doi: 10.1111/bcp.12040.
10
Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.药剂师对重症内科患者中可延长QTc间期药物的监测:一项试点研究。
Ann Pharmacother. 2008 Apr;42(4):475-82. doi: 10.1345/aph.1K458. Epub 2008 Mar 4.